Zellidja S.A. (CBSE:ZDJ)

Verve Therapeutics Revenue

In the year 2023, Zellidja had annual revenue of 610.21M MAD with 4.81% growth. Zellidja had revenue of 299.06M in the half year ending December 31, 2023, a decrease of -31.26%.

• Revenue: 610.21M
• Revenue Growth: +4.81%
• P/S Ratio: 0.26
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 158.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	610.21M	28.01M	4.81%
Dec 31, 2022	582.19M	147.16M	33.83%
Dec 31, 2020	435.03M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-